Margarita I. Chavez
Director/Board Member chez NEWRON PHARMACEUTICALS S.P.A.
Profil
Margarita I.
Chavez is currently a Director at Ambagon Therapeutics, Inc., Jnana Therapeutics, Inc., CTx Operations, Inc., New England Venture Capital Association, Inc., Nitrase Therapeutics, Inc., Newron Pharmaceuticals SpA, Enthera Srl, P33 Chicago, and Magnolia Neurosciences Corp.
She previously worked as a Director at Rodeo Therapeutics Corp., a Non-Executive Director at Creabilis Therapeutics Srl, and a Managing Director at AbbVie Ventures LLC.
Ms. Chavez also served as a Director at Paragen Bio Pty Ltd.
and as a Principal at Abbott Biotech Ventures, Inc. She obtained her undergraduate degree from Santa Clara University in 1994 and her graduate degree from The Santa Clara University School of Law in 1997.
Postes actifs de Margarita I. Chavez
Sociétés | Poste | Début |
---|---|---|
NEWRON PHARMACEUTICALS S.P.A. | Director/Board Member | 17/04/2024 |
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | Director/Board Member | - |
CTx Operations, Inc.
CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Director/Board Member | - |
New England Venture Capital Association, Inc.
New England Venture Capital Association, Inc. Miscellaneous Commercial ServicesCommercial Services New England Venture Capital Association, Inc. is a non-profit organization which operates as a catalyst, and advocate, and a resource for the innovation economy. The company is headquartered in Cambridge, MA. | Director/Board Member | - |
Nitrase Therapeutics, Inc.
Nitrase Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nitrase Therapeutics, Inc. develops drugs against newly discovered nitration enzyme. The firm provides disease modifying drugs for multiple additional aging-dependent diseases, such as neurodegenerative disease, heart disease and cancer. The company was founded by Irene Griswold-Prenner and is headquartered in Jackson, WY. | Director/Board Member | - |
Ambagon Therapeutics, Inc.
Ambagon Therapeutics, Inc. BiotechnologyHealth Technology Ambagon Therapeutics, Inc. provides healthcare services. It specializes in biotechnology. The company is headquartered in San Francisco, CA. | Director/Board Member | - |
Enthera Srl
Enthera Srl BiotechnologyHealth Technology Enthera Srl develops therapeutic solutions to treat diabetes. The company was founded in 1985 by in October 2016 by Maria Gabriella Camboni, Paolo Fiorina and Francesca D'Addio and is headquartered in Milan, Italy. | Director/Board Member | 01/07/2020 |
P33 Chicago
P33 Chicago Investment ManagersFinance P33 Chicago is an American private company. The firm functions as an alternative investment manager. Brad Henderson has been the CEO since 2018. | Director/Board Member | 01/04/2020 |
Magnolia Neurosciences Corp.
Magnolia Neurosciences Corp. BiotechnologyHealth Technology Magnolia Neurosciences Corp. operates as a drug discovery and development company. The firm focuses on the creation of a novel class of neuroprotective medicines. The company was founded in 2018 and is headquartered in Seattle, WA. | Director/Board Member | 01/08/2018 |
Anciens postes connus de Margarita I. Chavez
Sociétés | Poste | Fin |
---|---|---|
░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
░░░░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
░░░░░░░ ░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
░░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | - |
Formation de Margarita I. Chavez
Santa Clara University | Undergraduate Degree |
The Santa Clara University School of Law | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
NEWRON PHARMACEUTICALS S.P.A. | Health Technology |
Entreprise privées | 13 |
---|---|
New England Venture Capital Association, Inc.
New England Venture Capital Association, Inc. Miscellaneous Commercial ServicesCommercial Services New England Venture Capital Association, Inc. is a non-profit organization which operates as a catalyst, and advocate, and a resource for the innovation economy. The company is headquartered in Cambridge, MA. | Commercial Services |
Creabilis Therapeutics Srl
Creabilis Therapeutics Srl Pharmaceuticals: MajorHealth Technology Creabilis Therapeutics SRL discovers, develops, and markets prescription medicines to treat skin disease. Its products include CT200 and CT335, which is used to treat Behcet's disease; and CT327, which is used for the treatment of psoriasis, atopic dermatitis, and overgrowth of keratinocytes. The company’s products also include CT400, which is used for developing inhibitors of HGMB-1; and CT500 for the treatment of inflammatory disorders. The company was founded by Alfredo Boni in 2003 and is headquartered in Colleretto Giacosa, Italy. | Health Technology |
Abbott Biotech Ventures, Inc.
Abbott Biotech Ventures, Inc. Investment ManagersFinance Abbott Biotech Ventures, Inc. (Abbott Biotech Ventures) is a venture capital subsidiary of Abbott Laboratories. The firm is headquartered in Abbott Park, Illinois. | Finance |
CTx Operations, Inc.
CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Health Technology |
Rodeo Therapeutics Corp.
Rodeo Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Rodeo Therapeutics Corp. engages in the development of drugs. The firm develops novel small molecules therapies for the treatment of inflammatory bowel disease and the promotion of blood cell reconstitution following bone marrow transplant. It focuses on the development of small-molecule therapies that increase tissue levels of prostaglandin PGE2. The company was founded by Stanton Gerson, Sanford Markowitz, and Joseph Ready on May 15, 2017 and is headquartered in Seattle, WA. | Health Technology |
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | Health Technology |
Nitrase Therapeutics, Inc.
Nitrase Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nitrase Therapeutics, Inc. develops drugs against newly discovered nitration enzyme. The firm provides disease modifying drugs for multiple additional aging-dependent diseases, such as neurodegenerative disease, heart disease and cancer. The company was founded by Irene Griswold-Prenner and is headquartered in Jackson, WY. | Commercial Services |
Enthera Srl
Enthera Srl BiotechnologyHealth Technology Enthera Srl develops therapeutic solutions to treat diabetes. The company was founded in 1985 by in October 2016 by Maria Gabriella Camboni, Paolo Fiorina and Francesca D'Addio and is headquartered in Milan, Italy. | Health Technology |
Magnolia Neurosciences Corp.
Magnolia Neurosciences Corp. BiotechnologyHealth Technology Magnolia Neurosciences Corp. operates as a drug discovery and development company. The firm focuses on the creation of a novel class of neuroprotective medicines. The company was founded in 2018 and is headquartered in Seattle, WA. | Health Technology |
Paragen Bio Pty Ltd.
Paragen Bio Pty Ltd. BiotechnologyHealth Technology Paragen Bio Pty Ltd. operates as a biotechnology company which develops drugs for the treatment of autoimmune diseases. The company was founded by Alex Loukas, John Miles, Norelle Daly, and Paul Giacomin and is headquartered in Fortitude Valley, Australia. | Health Technology |
Ambagon Therapeutics, Inc.
Ambagon Therapeutics, Inc. BiotechnologyHealth Technology Ambagon Therapeutics, Inc. provides healthcare services. It specializes in biotechnology. The company is headquartered in San Francisco, CA. | Health Technology |
P33 Chicago
P33 Chicago Investment ManagersFinance P33 Chicago is an American private company. The firm functions as an alternative investment manager. Brad Henderson has been the CEO since 2018. | Finance |
AbbVie Ventures LLC
AbbVie Ventures LLC Investment ManagersFinance AbbVie Ventures LLC (AbbVie Ventures) is a venture capital firm, a subsidiary of AbbVie, Inc. founded in 2009. The firm is headquartered in North Chicago, Illinois. | Finance |